Kim Papp Selected Research

Kim Papp Research Topics

Disease

77	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2024 - 09/2004
20	Psoriatic Arthritis 03/2024 - 04/2009
19	Atopic Dermatitis (Atopic Eczema) 05/2024 - 07/2002
14	Infections 12/2022 - 07/2002
4	Respiratory Tract Infections (Respiratory Tract Infection) 12/2022 - 11/2016
4	Inflammation (Inflammations) 12/2022 - 08/2012
4	Nasopharyngitis 01/2022 - 04/2011
4	Neoplasms (Cancer) 02/2020 - 12/2005
3	Eczema 05/2024 - 07/2002
3	Myocardial Infarction 09/2023 - 03/2010
3	Chronic Disease (Chronic Diseases) 01/2023 - 01/2006
3	Acne Vulgaris 06/2022 - 02/2008
3	Headache (Headaches) 06/2022 - 07/2010
3	Pruritus (Itching) 09/2020 - 08/2002
2	Fatigue 01/2023 - 01/2006
2	Conjunctivitis 12/2022 - 03/2018
2	Injection Site Reaction 12/2022 - 11/2016
2	Nausea 06/2022 - 01/2022
2	Body Weight (Weight, Body) 01/2022 - 10/2015
2	Ulcerative Colitis 01/2021 - 02/2020
2	Rheumatoid Arthritis 01/2021 - 01/2017
2	Skin Neoplasms (Skin Cancer) 02/2020 - 07/2015
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2020 - 01/2018
2	Ankylosing Spondylitis 03/2019 - 04/2009
2	Candidiasis (Moniliasis) 01/2018 - 10/2015
2	Hypertension (High Blood Pressure) 01/2017 - 07/2012
2	Necrosis 01/2013 - 10/2005
1	Hidradenitis Suppurativa 10/2023
1	Pain (Aches) 01/2023
1	3 Atopic Dermatitis 01/2023
1	Opportunistic Infections (Opportunistic Infection) 12/2022
1	Kaposi Varicelliform Eruption (Eczema Herpeticum) 12/2022
1	Herpes Zoster 06/2022
1	Herpes Simplex 06/2022
1	Diarrhea 01/2022
1	Celiac Disease (Celiac Sprue) 01/2022

Drug/Important Bio-Agent (IBA)

16	Monoclonal AntibodiesIBA 02/2024 - 10/2005
11	CytokinesIBA 12/2022 - 07/2002
9	InterleukinsIBA 09/2023 - 12/2008
8	risankizumabIBA 03/2024 - 01/2022
8	Interleukin-17 (Interleukin 17)IBA 01/2022 - 07/2014
8	Adalimumab (Humira)FDA Link 01/2018 - 01/2008
7	brodalumabIBA 01/2024 - 12/2014
7	ixekizumabIBA 03/2022 - 01/2015
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 10/2005
6	ruxolitinibIBA 05/2024 - 01/2020
5	calcipotriene (calcipotriol)FDA LinkGeneric 02/2024 - 09/2010
5	apremilastIBA 01/2022 - 08/2012
5	Ointments (Pastes)IBA 01/2020 - 09/2010
4	Interleukin-23 (Interleukin 23)IBA 10/2023 - 01/2022
4	Ustekinumab (CNTO 1275)FDA Link 10/2015 - 12/2008
4	Etanercept (Enbrel)FDA Link 08/2015 - 01/2006
4	Infliximab (Remicade)FDA Link 07/2015 - 10/2005
4	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 10/2011 - 01/2010
4	Alefacept (Amevive)FDA Link 12/2009 - 12/2005
4	efalizumab (Raptiva)FDA Link 11/2008 - 12/2005
3	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 02/2024 - 01/2011
3	secukinumabIBA 09/2023 - 07/2014
3	Interleukin-13IBA 12/2022 - 01/2016
3	Janus Kinase InhibitorsIBA 06/2022 - 06/2020
3	omega-Chloroacetophenone (Mace)IBA 02/2020 - 07/2015
3	Phosphodiesterase 4 InhibitorsIBA 01/2020 - 07/2015
3	dupilumabIBA 09/2018 - 01/2016
3	Interleukin-12 (IL 12)IBA 01/2018 - 12/2008
3	SteroidsIBA 01/2018 - 07/2011
3	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 07/2015 - 08/2012
3	golimumab FDA Link 01/2013 - 04/2009
3	pimecrolimus (Elidel)FDA Link 12/2004 - 07/2002
2	Immunoglobulin A (IgA)IBA 05/2024 - 09/2017
2	upadacitinibIBA 11/2023 - 01/2021
2	Antirheumatic Agents (DMARD)IBA 11/2023 - 01/2022
2	guselkumabIBA 10/2023 - 09/2023
2	AerosolsIBA 06/2022 - 01/2016
2	baricitinibIBA 01/2022 - 07/2021
2	abrocitinibIBA 10/2020 - 09/2020
2	Calcineurin InhibitorsIBA 11/2011 - 03/2006
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2011 - 10/2011
2	Vitamin D FDA LinkGeneric 11/2011 - 10/2011
2	Calcitriol (Calcijex)FDA LinkGeneric 10/2011 - 07/2011
2	siplizumabIBA 07/2010 - 07/2009
1	Peptides (Polypeptides)IBA 02/2024
1	mirikizumabIBA 09/2023
1	Interleukin-23 Subunit p19IBA 09/2023
1	tralokinumabIBA 12/2022
1	Janus KinasesIBA 06/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 06/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	Glutens (Glutelin)IBA 01/2022
1	AntipruriticsIBA 10/2021
1	Janus Kinase 2IBA 07/2021
1	Janus Kinase 1IBA 07/2021
1	tofacitinibIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 10/2020
1	GSK2982772IBA 10/2020

Therapy/Procedure

33	Therapeutics 01/2023 - 09/2004
9	Biological Therapy 01/2024 - 02/2007
4	Phototherapy (Light Therapy) 07/2012 - 09/2004
2	Aftercare (After-Treatment) 07/2020 - 01/2016
1	Oral Administration 02/2024